Preview

Obstetrics, Gynecology and Reproduction

Advanced search

THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017

https://doi.org/10.17749/2313-7347.2017.11.3.116-126

Full Text:

Abstract

Within the framework of the 27th international conference «Reproductive technologies today and tomorrow», the first Russia-made follitropin alfa biosimilar for controlled ovarian stimulation in assisted reproductive technologies (ART) was presented. The follicle-stimulating hormone (FSH) biosimilar has undergone  all stages  of development in Russia, from the producer cells culture to the release of active FSH. Also the data are presented  on a prospective randomized crossover study of phase I  confirming the similarity of pharmacokinetics between the biosimilar and the original FSH. Another randomized multicenter phase III clinical study is now under way aiming to demonstrate the clinical equivalence between the biosimilar and the original FSH; preliminary  results  of this study are presented and discussed. As planned, the recombinant FSH biosimilar will be produced in disposable injectors (pen-injector) that provide easy-to-use handling, convenient dose setting and wide range dosing.

About the Authors

I. I. Vorobiev
Federal Research Centre «Fundamentals of Biotechnology», Russian Academy of Sciences (Research Center of Biotechnology RAS)
Russian Federation

Vorobiev Ivan Ivanovich – PhD, Associate Professor, Head of the Laboratory of Bioengineering of Mammalian  Cells.

Leninskiy pr., 33/2, Moscow, 119071



A. S. Semikhin
Branch «Medgamal» of Federal Research Center for Epidemiology and Microbiology named after honorary academician N.F. Gamaleya, Health Ministry of Russian Federation
Russian Federation

Semikhin Alexander Sergeevich – PhD, Head of the Biotechnological Products Department, Branch «Medgamal» of N.F. Gamaleya FRCEM.

Ul. Gamaleya, 18, Moscow, 123098


E. O. Golovina
IVFarma LLC
Russian Federation

Golovina Ekaterina Olegovna – Director of Marketing.

Nauchnyi  proezd,  20, str. 2, Moscow, 117246



For citation:


Vorobiev I.I., Semikhin A.S., Golovina E.O. THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017. Obstetrics, Gynecology and Reproduction. 2017;11(3):116-126. (In Russ.) https://doi.org/10.17749/2313-7347.2017.11.3.116-126

Views: 284


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)